老虎证券

Fresenius: Receives FDA Approval For Denosumab Biosimilars And Secures Global Settlement

Reuters
03/27
March 26 (Reuters) - FRESENIUS SE & CO KGAA ::
*FRESENIUS SE - RECEIVES FDA APPROVAL FOR THEIR DENOSUMAB BIOSIMILARS AND SECURES GLOBAL SETTLEMENT
*FRESENIUS SE - DENOSUMAB BIOSIMILARS ARE APPROVED FOR ALL INDICATIONS OF THE REFERENCE PRODUCTS PROLIA®* (DENOSUMAB) AND XGEVA®* (DENOSUMAB), RESPECTIVELY
*FRESENIUS SE - FRESENIUS’ OPERATING COMPANY REACHED GLOBAL SETTLEMENT WITH AMGEN, ALLOWING LAUNCH OF THESE BIOSIMILARS IN THE US FROM MID-2025 AND IN EUROPE LATER IN H2 OF 2025
*Further company coverage: FREG.DE
* (Gdansk Newsroom)
* ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))
Source Date/Time = 26-MAR-202516:00:00.487 GMT

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10